INE0DK501011
INE0DK501011
PIRAMAL PHARMA LIMITED
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 87.588.200.000 | 90.610.000.000 | 3.3% |
| Cost of Revenue | 35.836.300.000 | 35.721.300.000 | 0.3% |
| Gross Profit | 51.751.900.000 | 54.888.700.000 | 5.7% |
| 50.202.800.000 | 48.102.200.000 | 4.4% | |
| Operating Income | 1.549.100.000 | 6.786.500.000 | 77.2% |
| Pretax Income | -1.760.600.000 | 4.146.400.000 | 142.5% |
| Net Income Common Stockholders | -3.259.400.000 | 911.300.000 | 457.7% |
| -- | -- | -- | |
| -- | -- | -- |